MHUA Valuation
Meihua International Medical Technologies Co Ltd
$
0.390
- Overview
- Forecast
- Valuation
- Earnings
MHUA Relative Valuation
MHUA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MHUA is overvalued; if below, it's undervalued.
Historical Valuation
Meihua International Medical Technologies Co Ltd (MHUA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Meihua International Medical Technologies Co Ltd (MHUA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price：0.39
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Meihua International Medical Technologies Co Ltd. (MHUA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Meihua International Medical Technologies Co Ltd. (MHUA) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Meihua International Medical Technologies Co Ltd. (MHUA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Meihua International Medical Technologies Co Ltd. (MHUA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Meihua International Medical Technologies Co Ltd. (MHUA) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Meihua International Medical Technologies Co Ltd (MHUA) has a current Price-to-Book (P/B) ratio of 0.08. Compared to its 3-year average P/B ratio of 0.57 , the current P/B ratio is approximately -86.29% higher. Relative to its 5-year average P/B ratio of 0.65, the current P/B ratio is about -87.97% higher. Meihua International Medical Technologies Co Ltd (MHUA) has a Forward Free Cash Flow (FCF) yield of approximately 111.69%. Compared to its 3-year average FCF yield of 28.20%, the current FCF yield is approximately 296.04% lower. Relative to its 5-year average FCF yield of 24.23% , the current FCF yield is about 360.87% lower.
0.08
P/B
Median3y
0.57
Median5y
0.65
111.69
FCF Yield
Median3y
28.20
Median5y
24.23
Competitors Valuation Multiple
The average P/S ratio for MHUA's competitors is 0.21, providing a benchmark for relative valuation. Meihua International Medical Technologies Co Ltd Corp (MHUA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MHUA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MHUA in the past 1 year is driven by Unknown.
People Also Watch
GSIW
Garden Stage Ltd
0.122
USD
0.00%
CLRB
Cellectar Biosciences Inc
4.710
USD
+6.56%
RVYL
Ryvyl Inc
0.306
USD
-4.97%
XELB
Xcel Brands Inc
1.110
USD
0.00%
CLWT
Euro Tech Holdings Company Ltd
1.190
USD
0.00%
HOTH
Hoth Therapeutics Inc
1.300
USD
0.00%
WATT
Energous Corp
8.100
USD
0.00%
BREA
Brera Holdings PLC
6.780
USD
0.00%
INDP
Indaptus Therapeutics Inc
8.440
USD
0.00%
TSBX
Turnstone Biologics Corp
0.360
USD
+1.41%
FAQ
Is Meihua International Medical Technologies Co Ltd (MHUA) currently overvalued or undervalued?
Meihua International Medical Technologies Co Ltd (MHUA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Meihua International Medical Technologies Co Ltd (MHUA) is between to according to relative valuation methord.
What is Meihua International Medical Technologies Co Ltd (MHUA) fair value?
How does MHUA's valuation metrics compare to the industry average?
What is the current P/B ratio for Meihua International Medical Technologies Co Ltd (MHUA) as of Aug 14 2025?
What is the current FCF Yield for Meihua International Medical Technologies Co Ltd (MHUA) as of Aug 14 2025?
What is the current Forward P/E ratio for Meihua International Medical Technologies Co Ltd (MHUA) as of Aug 14 2025?